VDAC1 and cancer: In vitro studies demonstrated that VDA-1102 selectively detaches HK2, but not HK1, from VDAC1 leading to cancer cell apoptosis as well as glycolysis inhibition and reduction in lactate secretion, culminating in proliferation inhibition.